Literature DB >> 14563501

Is geography destiny for patients in New York with myocardial infarction?

Jing Fang1, Michael H Alderman.   

Abstract

PURPOSE: The use of coronary revascularization among patients with myocardial infarction varies by race/ethnicity and socioeconomic status. The objective of this study was to determine whether local availability of facilities might influence apparent racial disparities in revascularization and health outcomes.
METHODS: Using Statewide Planning and Research Cooperative System data (1988-1999) from the New York State Department of Health, we determined revascularization rates among patients hospitalized with myocardial infarction in two socioeconomically disadvantaged communities in New York City (the South Bronx, which has no hospitals that have revascularization facilities, and Harlem, which has three revascularization facilities), as well as in its most advantaged community (mid-Manhattan, which has six such facilities). The rest of New York City served as reference. We measured demographic and clinical characteristics and revascularization rates in each community.
RESULTS: Among patients hospitalized with myocardial infarction, the age-adjusted revascularization rates were 29.2% for whites, 12.5% for blacks, and 19.9% for Hispanics (P <0.01). Rates were 12.0% in the South Bronx, 24.0% in Harlem, 38.4% in mid-Manhattan, and 21.2% in the rest of New York City (P <0.05). Logistic regression analysis, adjusting for age, sex, race, insurance status, comorbidity, clinical complications, and year of admission, revealed that South Bronx patients were about 20% less likely to be revascularized than those in the rest of New York City, whereas patients living in Harlem were twice as likely to receive such treatment as residents in the rest of New York City. Among patients admitted to hospitals with cardiac revascularization facilities, lower use among South Bronx residents persisted, but after adjusting for patient characteristics, Harlem residents were significantly less likely to be revascularized than those from the rest of New York City.
CONCLUSION: Race and socioeconomic factors influence the likelihood of revascularization after myocardial infarction among residents of New York City. In addition, lack of availability of revascularization further reduces its use by residents of disadvantaged neighborhoods.

Entities:  

Mesh:

Year:  2003        PMID: 14563501     DOI: 10.1016/s0002-9343(03)00446-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Access to revascularization among patients with acute myocardial infarction in New York City--impact of hospital resources.

Authors:  Jing Fang; Abdissa Negassa; Robert W Gern; Michael H Alderman
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

2.  Health disparities: a barrier to high-quality care.

Authors:  C Daniel Mullins; Lisa Blatt; Confidence M Gbarayor; Hui-Wen Keri Yang; Claudia Baquet
Journal:  Am J Health Syst Pharm       Date:  2005-09-15       Impact factor: 2.637

3.  Regional variation in kidney transplant outcomes: trends over time.

Authors:  Harini A Chakkera; Glenn M Chertow; Ann M O'Hare; William J Amend; Thomas A Gonwa
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

4.  Is thirty-day hospital mortality really lower for black veterans compared with white veterans?

Authors:  Kevin G Volpp; Roslyn Stone; Judith R Lave; Ashish K Jha; Mark Pauly; Heather Klusaritz; Huanyu Chen; Liyi Cen; Nancy Brucker; Daniel Polsky
Journal:  Health Serv Res       Date:  2007-08       Impact factor: 3.402

5.  Neighborhood Variation in Rate of Revascularization among Acute Myocardial Infarction Patients in New York City.

Authors:  Abdissa Negassa; Jing Fang
Journal:  Cardiol Res Pract       Date:  2011-10-19       Impact factor: 1.866

6.  The role of invasive therapies in elderly patients with acute myocardial infarction.

Authors:  José C Nicolau; Pedro A Lemos; Maurício Wajngarten; Roberto R Giraldez; Carlos V Serrano; Eulógio E Martinez; Luciano M Baracioli; Roberto Kalil; Fábio B Jatene; Luis A Dallan; Luis B Puig; Noedir A Stolf
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.